26 May 2013
Keywords: isolagen, appoints, sandra, calman, vp, biotechnology, company
Article | 19 February 2007
US biotechnology company Isolagen has appointed Sandra Calman as vice president and chief medical officer. Dr Calman comes to the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 February 2007
24 May 2013
© 2013 thepharmaletter.com